Renal function: the Cinderella of cardiovascular risk profile (Q34459987)

2 August 2017

1 reference

title

Renal function: the Cinderella of cardiovascular risk profile (English)

1 reference

2 August 2017

1 reference

Ruilope LM

1

1 reference

2 August 2017

van Veldhuisen DJ

series ordinal

2

1 reference

2 August 2017

Ritz E

series ordinal

3

1 reference

2 August 2017

Luscher TF

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Journal of the American College of Cardiology

2 August 2017

1 reference

2 August 2017

38

1 reference

2 August 2017

7

1 reference

2 August 2017

1782-1787

1 reference

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Clinical relevance of proteinuria and microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Longitudinal studies on the rate of decline in renal function with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Serum uric acid in essential hypertension: an indicator of renal vascular involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Kidneys and primary hypertension--initiators, stabilizers or/and victim-aggravators?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Hypertensive vascular disease; description and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Blood pressure and renal function: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

The prognostic significance of proteinuria: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Increased systolic pressure in chronic uremia. Role of arterial wave reflections

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Insulin resistance, elevated glomerular filtration fraction, and renal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Serum uric acid and cardiovascular events in successfully treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Hyperuricemia and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Hormones and hemodynamics in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Exaggerated renal vasoconstriction during exercise in heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Risks associated with renal dysfunction in patients in the coronary care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901627-8

7 January 2021

10.1016/S0735-1097(01)01627-8

Identifiers

DOI

1 reference

release_u4wsgpjj55b6voyfia5vm36lk4

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u4wsgpjj55b6voyfia5vm36lk4

24 November 2022

mapped directly with Wikidata item

1 reference